{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:50:04Z","timestamp":1791975004488,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["60-64400-98-210"],"award-info":[{"award-number":["60-64400-98-210"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010378","name":"Stichting Wetenschappelijk Onderzoek Oogziekenhuis","doi-asserted-by":"publisher","award":["2021S05"],"award-info":[{"award-number":["2021S05"]}],"id":[{"id":"10.13039\/501100010378","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010372","name":"Rotterdamse Stichting Blindenbelangen","doi-asserted-by":"publisher","award":["B20220001"],"award-info":[{"award-number":["B20220001"]}],"id":[{"id":"10.13039\/501100010372","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010331","name":"Stichting voor Ooglijders","doi-asserted-by":"publisher","award":["2021-09"],"award-info":[{"award-number":["2021-09"]}],"id":[{"id":"10.13039\/501100010331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In this study we explore the quality-of-life impact of vitreous floaters, and identify all possible issues that may be relevant to a person experiencing floaters, with the aim to define the content of a floaters-specific patient-reported outcome measure, which can help determine the disease burden and benefit of treatment for a patient with floaters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>Semi-structured telephone interviews were conducted with patients with floaters. The topic guide was based on an extensive literature review and expert opinion. Interview transcripts were coded into all possible quality-of-life issues that may be relevant to a person experiencing floaters. We grouped these into quality-of-life domains and subdomains, using an earlier framework of quality of life in other ophthalmic diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We categorized the patients\u2019 reports (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200944) into 11 quality-of-life domains: activity limitations, visual symptoms, ocular symptoms, general symptoms, health concerns, emotional well-being, social well-being, mobility issues, economic impact, inconveniences, and the need to use coping strategies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Vitreous floaters result in specific quality-of-life issues that have not been adequately measured with previous patient-reported outcome measures. When compared to other eye conditions, three previously unidentified issues stand out among patients with floaters: the effects of different lighting conditions, intermittent vision impairment caused by eye movements, and the importance of seeking understanding and support from healthcare providers. Eye care clinicians should recognize these issues when evaluating patients with floaters. The present patient-driven determination of relevant quality-of-life issues can guide initiatives in floaters-specific patient-reported outcome measures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41687-025-00934-w","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T07:59:51Z","timestamp":1755503991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The impact of vitreous floaters on quality of life: a qualitative study"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7842-2180","authenticated-orcid":false,"given":"Jarinne E.","family":"Woudstra-de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5477-5499","authenticated-orcid":false,"given":"Sonia S.","family":"Manning-Charalampidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0441-2809","authenticated-orcid":false,"given":"Johannes Hans R.","family":"Vingerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2859-8975","authenticated-orcid":false,"given":"S. J. Feike","family":"Gerbrandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6322-9369","authenticated-orcid":false,"given":"Konrad","family":"Pesudovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8602-0381","authenticated-orcid":false,"given":"Jan J.","family":"Busschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"934_CR1","doi-asserted-by":"publisher","first-page":"110729","DOI":"10.1016\/j.jpsychores.2022.110729","volume":"154","author":"H Senra","year":"2022","unstructured":"Senra H, Ali Z, Aslam T, Patton N (2022) Psychological implications of vitreous opacities\u2013A systematic review. J Psychosom Res 154:110729. https:\/\/doi.org\/10.1016\/j.jpsychores.2022.110729","journal-title":"J Psychosom Res"},{"issue":"1","key":"934_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ajo.2011.01.026","volume":"152","author":"AM Wagle","year":"2011","unstructured":"Wagle AM, Lim W-Y, Yap T-P, Neelam K, Eong K-GA (2011) Utility values associated with vitreous floaters. Am J Ophthalmol 152(1):60\u201365. https:\/\/doi.org\/10.1016\/j.ajo.2011.01.026","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"934_CR3","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s11136-012-0256-x","volume":"22","author":"H Zou","year":"2013","unstructured":"Zou H, Liu H, Xu X, Zhang X (2013) The impact of persistent visually disabling vitreous floaters on health status utility values. Qual Life Res 22(6):1507\u20131514. https:\/\/doi.org\/10.1007\/s11136-012-0256-x","journal-title":"Qual Life Res"},{"issue":"2","key":"934_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/APO.0000000000000189","volume":"5","author":"MJ Tassignon","year":"2016","unstructured":"Tassignon MJ, Ruiz Hidalgo SND, Rozema I (2016) Subjective grading of subclinical vitreous floaters. Asia Pac J Ophthalmol 5(2):104\u2013109. https:\/\/doi.org\/10.1097\/APO.0000000000000189","journal-title":"Asia Pac J Ophthalmol"},{"key":"934_CR5","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1007\/s00417-024-06477-y","volume":"262","author":"H Senra","year":"2024","unstructured":"Senra H, Ali Z, Aslam T et al (2024) Personality traits and symptoms of anxiety and depression in patients with primary vitreous floaters. Graefes Arch Clin Exp Ophthalmol 262:3153\u20133160. https:\/\/doi.org\/10.1007\/s00417-024-06477-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"934_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41433-020-0825-0","volume":"34","author":"EO Zeydanli","year":"2020","unstructured":"Zeydanli EO, Parolini B, Ozdek S, Bopp S, Adelman RA, Kuhn F, Aksakal N (2020) Management of vitreous floaters: an international survey the European vitreoretinal society floaters study report. Eye 34(5):825\u2013834. https:\/\/doi.org\/10.1038\/s41433-020-0825-0","journal-title":"Eye"},{"issue":"2","key":"934_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.survophthal.2015.11.008","volume":"61","author":"R Milston","year":"2016","unstructured":"Milston R, Madigan MC, Sebag J (2016) Vitreous floaters: etiology, diagnostics, and management. Surv Ophthalmol 61(2):211\u2013227. https:\/\/doi.org\/10.1016\/j.survophthal.2015.11.008","journal-title":"Surv Ophthalmol"},{"key":"934_CR8","doi-asserted-by":"publisher","first-page":"100847","DOI":"10.1016\/j.preteyeres.2020.100847","volume":"79","author":"J Sebag","year":"2020","unstructured":"Sebag J (2020) Vitreous and vision degrading myodesopsia. Prog Retin Eye Res 79:100847. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100847","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"934_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.survophthal.2023.06.003","volume":"68","author":"JE Woudstra-de Jong","year":"2023","unstructured":"Woudstra-de Jong JE, Manning-Charalampidou SS, Vingerling H, Busschbach JJ, Pesudovs K (2023) Patient-reported outcomes in patients with vitreous floaters: a systematic literature review. Surv Ophthalmol 68(5):875\u2013888. https:\/\/doi.org\/10.1016\/j.survophthal.2023.06.003","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"934_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-12-15","volume":"12","author":"A Br\u00e9dart","year":"2014","unstructured":"Br\u00e9dart A, Marrel A, Abetz-Webb L, Lasch K, Acquadro C (2014) Interviewing to develop Patient-Reported outcome (PRO) measures for clinical research: eliciting patients\u2019 experience. Health Qual Life Outcomes 12(1):1\u201310. https:\/\/doi.org\/10.1186\/1477-7525-12-15","journal-title":"Health Qual Life Outcomes"},{"key":"934_CR11","unstructured":"U.S: Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research (2022) Patient-focused drug development: Methods to identify what is important to patients. Available via FDA. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-focused-drug-development-methods-identify-what-important-patients. Accessed 6 May 2025"},{"issue":"8","key":"934_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L (2011) Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1\u2014eliciting concepts for a new PRO instrument. Value Health 14(8):967\u2013977. https:\/\/doi.org\/10.1016\/j.jval.2011.06.014","journal-title":"Value Health"},{"issue":"11","key":"934_CR13","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1177\/1049732312456604","volume":"22","author":"S Cipolletta","year":"2012","unstructured":"Cipolletta S, Beccarello A, Galan A (2012) A psychological perspective of eye floaters. Qual Health Res 22(11):1547\u20131558. https:\/\/doi.org\/10.1177\/1049732312456604","journal-title":"Qual Health Res"},{"issue":"1","key":"934_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41687-017-0023-4","volume":"1","author":"M Prem Senthil","year":"2017","unstructured":"Prem Senthil M, Khadka J, Gilhotra JS, Simon S, Pesudovs K (2017) Exploring the quality of life issues in people with retinal diseases: a qualitative study. J Patient-Rep Outcomes 1(1):1\u201314. https:\/\/doi.org\/10.1186\/s41687-017-0023-4","journal-title":"J Patient-Rep Outcomes"},{"key":"934_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41433-022-02073-8","volume":"37","author":"A Yoganathan","year":"2022","unstructured":"Yoganathan A, Sandinha T, Shamdas M, Diafas A, Steel D (2022) Patient-reported outcome measures in vitreoretinal surgery: a systematic review. Eye 37:391\u2013401. https:\/\/doi.org\/10.1038\/s41433-022-02073-8","journal-title":"Eye"},{"issue":"12","key":"934_CR16","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/OPX.0000000000000992","volume":"93","author":"J Khadka","year":"2016","unstructured":"Khadka J, Fenwick E, Lamoureux E, Pesudovs K (2016) Methods to develop the eye-tem bank to measure ophthalmic quality of life. Optom Vis Sci 93(12):1485\u20131494. https:\/\/doi.org\/10.1097\/OPX.0000000000000992","journal-title":"Optom Vis Sci"},{"issue":"3","key":"934_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ogla.2021.09.007","volume":"5","author":"LS Knight","year":"2022","unstructured":"Knight LS, Ridge B, Staffieri SE, Craig JE, Senthil MP, Souzeau E (2022) Quality of life in adults with childhood glaucoma: an interview study. Ophthalmol Glaucoma 5(3):325\u2013336. https:\/\/doi.org\/10.1016\/j.ogla.2021.09.007","journal-title":"Ophthalmol Glaucoma"},{"issue":"5","key":"934_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/09286586.2020.1856385","volume":"28","author":"M Prem Senthil","year":"2021","unstructured":"Prem Senthil M, Lim L, Braithwaite T et al (2021) The impact of adult uveitis on quality of life: an exploratory study. Ophthalmic Epidemiol 28(5):444\u2013452. https:\/\/doi.org\/10.1080\/09286586.2020.1856385","journal-title":"Ophthalmic Epidemiol"},{"issue":"10","key":"934_CR19","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s11136-012-0110-1","volume":"21","author":"EK Fenwick","year":"2012","unstructured":"Fenwick EK, Pesudovs K, Khadka J et al (2012) The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project. Qual Life Res 21(10):1771\u20131782. https:\/\/doi.org\/10.1007\/s11136-012-0110-1","journal-title":"Qual Life Res"},{"issue":"8","key":"934_CR20","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/OPX.0000000000000320","volume":"91","author":"C McCloud","year":"2014","unstructured":"McCloud C, Khadka J, Gilhotra JS, Pesudovs K (2014) Divergence in the lived experience of people with macular degeneration. Optom Vis Sci 91(8):966\u2013974. https:\/\/doi.org\/10.1097\/OPX.0000000000000320","journal-title":"Optom Vis Sci"},{"issue":"7","key":"934_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/ceo.12954","volume":"45","author":"H Kandel","year":"2017","unstructured":"Kandel H, Khadka J, Goggin M, Pesudovs K Impact of refractive error on quality of life: a qualitative study. Clin Exp Ophthalmol (2017);45(7):677\u2013688. https:\/\/doi.org\/10.1111\/ceo.12954","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"934_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/eye.2016.315","volume":"31","author":"M Prem Senthil","year":"2017","unstructured":"Prem Senthil M, Khadka J, Pesudovs K (2017) Seeing through their eyes: lived experiences of people with retinitis pigmentosa. Eye 31(5):741\u2013748. https:\/\/doi.org\/10.1038\/eye.2016.315","journal-title":"Eye"},{"issue":"4","key":"934_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/cxo.12875","volume":"102","author":"M Prem Senthil","year":"2019","unstructured":"Prem Senthil M, Khadka J, Gilhotra JS et al Understanding quality of life impact in people with retinal vein occlusion: a qualitative inquiry. Clin Exp Ophthalmol. (2019) ;102(4):406\u2013411. doi: https:\/\/doi.org\/10.1111\/cxo.12875","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"934_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/opo.12610","volume":"39","author":"SE Kumaran","year":"2019","unstructured":"Kumaran SE, Khadka J, Baker R, Pesudovs K (2019) Functional limitations recognised by adults with amblyopia and strabismus in daily life: a qualitative exploration. Ophthalmic Physiol Opt 39(3):131\u2013140. https:\/\/doi.org\/10.1111\/opo.12610","journal-title":"Ophthalmic Physiol Opt"},{"key":"934_CR25","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00417-018-3998-5","volume":"256","author":"M Prem Senthil","year":"2018","unstructured":"Prem Senthil M, Khadka J, De Roach J et al (2018) Developing an item bank to measure the coping strategies of people with hereditary retinal diseases. Graefes Arch Clin Exp Ophthalmol 256:1291\u20131298. https:\/\/doi.org\/10.1007\/s00417-018-3998-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"934_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/s0001-2092(06)61812-7","volume":"73","author":"MM Byrne","year":"2001","unstructured":"Byrne MM (2001) Understanding life experiences through a phenomenological approach to research. AORN J 73(4):830\u2013830. https:\/\/doi.org\/10.1016\/s0001-2092(06)61812-7","journal-title":"AORN J"},{"key":"934_CR27","unstructured":"Ltd QIP (2020) NVivo [computer software], 12 edn. QSR International Pty Ltd"},{"issue":"5","key":"934_CR28","doi-asserted-by":"publisher","first-page":"e0232076","DOI":"10.1371\/journal.pone.0232076","volume":"15","author":"G Guest","year":"2020","unstructured":"Guest G, Namey E, Chen M (2020) A simple method to assess and report thematic saturation in qualitative research. PLoS ONE 15(5):e0232076. https:\/\/doi.org\/10.1371\/journal.pone.0232076","journal-title":"PLoS ONE"},{"key":"934_CR29","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders B, Sim J, Kingstone T et al (2018) Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant 52:1893\u20131907. https:\/\/doi.org\/10.1007\/s11135-017-0574-8","journal-title":"Qual Quant"},{"issue":"6","key":"934_CR30","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/fampra\/13.6.522","volume":"13","author":"MN Marshall","year":"1996","unstructured":"Marshall MN (1996) Sampling for qualitative research. Fam Pract 13(6):522\u2013526. https:\/\/doi.org\/10.1093\/fampra\/13.6.522","journal-title":"Fam Pract"},{"issue":"7","key":"934_CR31","doi-asserted-by":"publisher","first-page":"7949","DOI":"10.3390\/ijerph120707949","volume":"12","author":"GL Tseng","year":"2015","unstructured":"Tseng GL, Chen CY (2015) Doctor-shopping behavior among patients with eye floaters. Int J Environ Res 12(7):7949\u20137958. https:\/\/doi.org\/10.3390\/ijerph120707949","journal-title":"Int J Environ Res"},{"issue":"8","key":"934_CR32","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3928\/23258160-20150909-11","volume":"46","author":"MN Cohen","year":"2015","unstructured":"Cohen MN, Rahimy E, Ho AC, Garg SJ (2015) Management of symptomatic floaters: current attitudes, beliefs, and practices among vitreoretinal surgeons. Ophthalmic Surg Lasers Imaging Retina 46(8):859\u2013865. https:\/\/doi.org\/10.3928\/23258160-20150909-11","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"934_CR33","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","volume":"27","author":"CB Terwee","year":"2018","unstructured":"Terwee CB, Prinsen CA, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, Mokkink LB (2018) COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res 27:1159\u20131170. https:\/\/doi.org\/10.1007\/s11136-018-1829-0","journal-title":"Qual Life Res"},{"key":"934_CR34","doi-asserted-by":"publisher","unstructured":"Gagnier JJ, Lai J, Mokkink LB, Terwee CB. COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Qual Life Res 2021:30;2197\u20132218. https:\/\/doi.org\/10.1186\/1471-2288-10-22","DOI":"10.1186\/1471-2288-10-22"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00934-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-025-00934-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00934-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:25:52Z","timestamp":1781605552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41687-025-00934-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1186\/s41687-025-00934-w","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Science Committee of the Rotterdam Eye Hospital (protocol number: OZR-2021-22) and adhered to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This submission has not been published anywhere previously and it is not simultaneously being considered for any other publication. It has previously been reviewed and rejected by 5 ophthalmological journals: Ophthalmology Retina (submitted: 28 Aug 2023, rejected: 25 Sep 2023), RETINA (submitted: 5 Mar 2024, rejected: 14 Jul 2024), Eye (submitted: 26 Jun 2024, rejected: 5 Nov 2024), Graefe\u2019s Archive for Clinical and Experimental Ophthalmology (submitted: 14 Nov 2024, rejected: 1 Jan 2025), and Ophthalmic Epidemiology (submitted: 5 Jan 2025, rejected: 24 Feb 2025).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous submissions"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}